US Capitol Capsule: US must lead in combating antimicrobial resistance, group urges
This article was originally published in Scrip
Executive Summary
The US must take the lead in a multipronged effort to combat antimicrobial resistance (AMR) and needs a well-financed, coordinated and actionable national plan with measurable goals, timelines and mechanisms for accountability, the Infectious Diseases Society of America (IDSA) declared on the eve before the start of the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington.